https://www.openbell.ai/ 2026-10-14T19:35:08.156Z hourly 1.0 https://www.openbell.ai/support 2026-10-14T19:35:08.156Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-14T19:35:08.156Z monthly 0.5 https://www.openbell.ai/terms 2026-10-14T19:35:08.156Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-14T19:35:08.156Z hourly 0.8 https://www.openbell.ai/news/AEHL:1792005555042 2026-10-14T19:19:15.042Z daily 0.9 https://cdn.brandfetch.io/AEHL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Antelope Enterprise Shares Halted On Circuit Breaker To The Downside, Stock Now Up 45.96% openbell Financial News https://www.openbell.ai/news/WFF:1792005481681 2026-10-14T19:18:01.681Z daily 0.9 https://cdn.brandfetch.io/WFF/w/400/h/400?c=1idopYfmtR7ZKg8QMud WF Holding Shares Halted On Circuit Breaker To The Downside, Stock Now Down -30.66% openbell Financial News https://www.openbell.ai/news/BTCUSD:1792005016510 2026-10-14T19:10:16.510Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Bitcoin-Hits-Record-109-000-Ahead-Of-Tru.jpg?width=250&height=187 Bitcoin Dips to $82,000 on Inflation Scare: Where Does BTC Go Next? Bitcoin (BTC) dropped to $82,000 amid concerns over rising U.S. inflation, with the headline Consumer Price Index (CPI) increasing to 3.7%, surpassing the expected 3.6%. Despite this selloff, institutional demand appears to be recovering, as U.S. spot Bitcoin ETFs recorded $175.6 million in daily net inflows. Analysts noted that Bitcoin's declining volatility could signal a significant price move ahead, while $83,000 is identified as a critical technical level for the cryptocurrency. https://www.openbell.ai/news/INTU:1792004598986 2026-10-14T19:03:18.986Z daily 0.9 https://cdn.brandfetch.io/INTU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Intuit Intelligence Now Available Internationally, Fueling Success For Businesses And Accountants On One Unified Platform Intuit has announced the international availability of its Intuit Intelligence platform, designed to support businesses and accountants with a unified solution. This strategic move aims to enhance operational efficiency and drive success for users globally. The expansion is expected to strengthen Intuit's market position and potentially impact its revenue growth in the coming quarters. https://www.openbell.ai/news/SPCE:1792004330610 2026-10-14T18:58:50.610Z daily 0.9 https://cdn.brandfetch.io/SPCE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of space-related companies are trading lower as U.S. inflation data fuel a spike in bond and Treasury yields, with expectations for interest rates to remain elevated. Monetary tightening and elevated borrowing costs pose a material threat to the sector from curtailed corporate and government financing of cosmic communications, AI compute, and exploration. openbell Financial News https://www.openbell.ai/news/MRX:1792004175011 2026-10-14T18:56:15.011Z daily 0.9 https://cdn.brandfetch.io/MRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Marex Group with Outperform Rating William Blair analyst Jeff Schmitt has initiated coverage on Marex Group (NASDAQ: MRX) with an Outperform rating. This marks a positive outlook for the company's stock performance in the market. https://www.openbell.ai/news/JSPR:1792003912504 2026-10-14T18:51:52.504Z daily 0.9 https://cdn.brandfetch.io/JSPR/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Reinstates Outperform on Jasper Therapeutics William Blair analyst Matt Phipps has reinstated an 'Outperform' rating on Jasper Therapeutics (NASDAQ: JSPR). This action indicates a positive outlook for the company's stock performance in the market. https://www.openbell.ai/news/NFLX:1792003422126 2026-10-14T18:43:42.126Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Netflix.jpg?width=250&height=187 Netflix Hasn't Cut This Many Jobs Since Its Subscriber Scare. So Why Now? Netflix Inc. (NASDAQ: NFLX) is laying off approximately 1,000 employees, or about 6% of its workforce, marking its largest job cuts since 2022. The layoffs primarily affect the product, tech, legal, and human resources teams, despite management asserting that the business remains strong and on track for its full-year forecast. Netflix's stock has declined about 25% this year, attributed to slower revenue growth and increased competition, particularly from platforms like YouTube and TikTok. The company anticipates a 10% rise in content spending this year, prompting the workforce reduction to help manage costs. https://www.openbell.ai/news/BE:1792003403195 2026-10-14T18:43:23.195Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Bloom-Energy.jpg?width=250&height=187 Bloom Energy Stock Slides Amid High Oil Prices and Inflation Woes Bloom Energy Corp (NYSE: BE) shares fell 9.87% to $237.46 amid rising oil prices and inflation concerns, which have heightened fears of prolonged high U.S. interest rates. The September inflation rate increased by 3.7%, surpassing economists' expectations, leading to pressure on rate-sensitive stocks. Investors are worried that expensive financing could delay or reduce new data center and infrastructure projects, potentially impacting Bloom Energy's order volume for fuel cells used in data centers. https://www.openbell.ai/news/KO:1792003355536 2026-10-14T18:42:35.536Z daily 0.9 https://cdn.brandfetch.io/KO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Coca-Cola, Raises Price Target to $102 Citigroup analyst Filippo Falorni has maintained a 'Buy' rating on Coca-Cola (NYSE: KO) and increased the price target from $100 to $102. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/AMD:1792003189193 2026-10-14T18:39:49.193Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Jakarta-May-02-2024-Advanced-Micro-Devic.jpg?width=250&height=187 Why Is AMD Stock Falling on Wednesday? Advanced Micro Devices Inc. (NASDAQ: AMD) saw its stock drop 5.43% to $572.62 on Wednesday, influenced by a broader semiconductor market decline amid rising inflation concerns. The Consumer Price Index rose 3.7% year-over-year in September, exceeding forecasts, which led to increased Treasury yields. Additionally, skepticism regarding the monetization of artificial intelligence infrastructure and a significant downward revision of OpenAI's annualized revenue from $70 billion to $50 billion contributed to the negative sentiment in the tech sector. https://www.openbell.ai/news/MARA:1792002986230 2026-10-14T18:36:26.230Z daily 0.9 https://cdn.brandfetch.io/MARA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of crypto-linked companies are trading lower as Bitcoin prices decline following the latest inflation data. Stronger-than-expected inflation has fueled expectations for tighter Federal Reserve policy, while rising Treasury yields and a stronger dollar are dampening risk appetite and weighing on speculative assets. openbell Financial News https://www.openbell.ai/news/GS:1792002868058 2026-10-14T18:34:28.058Z daily 0.9 https://cdn.brandfetch.io/GS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of banks and financial services companies are trading lower after U.S. core inflation data bolstered the case for more Fed monetary tightening, which may slow lending and limit interest margins. Also, weak Q3 segment results from Bank of America and Morgan Stanley may dent confidence in the broader sector. openbell Financial News https://www.openbell.ai/news/BRK:1792002864007 2026-10-14T18:34:24.007Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: Berkshire Stock Is Doing Something It Hasn’t Done Since January 2018 Berkshire Hathaway Inc. (NYSE: BRK) is experiencing a notable stock performance, with shares on track to close their 10th consecutive session of gains, rising 4.9% to approximately $522 since October 1. This marks the first 10-day winning streak for the company since January 2018, a feat achieved only six times in its history since 1996. Additionally, Berkshire has invested $330 million in AI software firm Bending Spoons (NASDAQ: BSP), further diversifying its portfolio. https://www.openbell.ai/news/ELF:1792002801391 2026-10-14T18:33:21.391Z daily 0.9 https://cdn.brandfetch.io/ELF/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on e.l.f. Beauty, Raises Price Target to $130 Citigroup analyst Filippo Falorni has reaffirmed a 'Buy' rating on e.l.f. Beauty (NYSE: ELF) and increased the price target from $118 to $130. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/FCX:1792002702220 2026-10-14T18:31:42.220Z daily 0.9 https://cdn.brandfetch.io/FCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of copper-related companies are trading lower amid a decline in copper prices and a stronger U.S. dollar following hotter-than-expected inflation data. openbell Financial News https://www.openbell.ai/news/BLK:1792002541719 2026-10-14T18:29:01.719Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Konskie--Poland---November-12--2024-Blac.jpg?width=250&height=187 BlackRock Expects Strong Fourth Quarter as AI Investment, Fundraising Grow BlackRock Inc. (NYSE: BLK) reported a 19% year-over-year revenue growth in Q3, reaching $7.75 billion, surpassing analyst expectations. The company plans to repurchase at least $550 million in shares in Q4 and sees growth opportunities in AI and private markets, having raised $68 billion in private markets over the past year. BlackRock's adjusted earnings were $15.93 per share, exceeding the consensus estimate of $14.13, with strong inflows across its business segments. https://www.openbell.ai/news/AMD:1792002515130 2026-10-14T18:28:35.130Z daily 0.9 https://cdn.brandfetch.io/AMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor and chip companies are trading lower amid elevated expectations for Fed rate hikes due to broader inflation and energy challenges. Higher borrowing costs may affect the sector's ambitious capex plans while also creating risks for customers, which may be reflected in lower demand. openbell Financial News https://www.openbell.ai/news/CCJ:1792002404046 2026-10-14T18:26:44.046Z daily 0.9 https://cdn.brandfetch.io/CCJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of uranium and nuclear-related companies are trading lower as hotter-than-expected inflation data fuels a rise in Treasury yields and expectations for interest rates to remain elevated. Elevated borrowing costs could increase financing expenses for capital-intensive nuclear projects, potentially delaying development timelines and weighing on investor sentiment toward the sector. openbell Financial News https://www.openbell.ai/news/PG:1792002374318 2026-10-14T18:26:14.318Z daily 0.9 https://cdn.brandfetch.io/PG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Procter & Gamble, Raises Price Target to $180 Citigroup analyst Filippo Falorni has reaffirmed a Buy rating on Procter & Gamble (NYSE: PG) and increased the price target from $170 to $180. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/BDRX:1792002271487 2026-10-14T18:24:31.487Z daily 0.9 https://cdn.brandfetch.io/BDRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Biodexa Pharmaceuticals shares are trading higher after the company announced it enrolled 100 patients in its registrational Phase 3 trial of eRapa in Familial Adenomatous Polyposis. openbell Financial News https://www.openbell.ai/news/NOW:1792001982512 2026-10-14T18:19:42.512Z daily 0.9 https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on ServiceNow, Raises Price Target to $170 Citigroup analyst Tyler Radke has reaffirmed a Buy rating on ServiceNow (NYSE: NOW) and increased the price target from $154 to $170. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/AAPG:1792001788388 2026-10-14T18:16:28.388Z daily 0.9 https://cdn.brandfetch.io/AAPG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $46 Citigroup analyst Yigal Nochomovitz has initiated coverage on Ascentage Pharma Group (NASDAQ: AAPG) with a Buy rating. The firm has set a price target of $46 for the company's stock. https://www.openbell.ai/news/TRDA:1792001720162 2026-10-14T18:15:20.162Z daily 0.9 https://cdn.brandfetch.io/TRDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With Entrada Therapeutics Stock Wednesday? Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported topline results from its Phase 1/2 ELEVATE-45-201 clinical trial, evaluating the drug ENTR-601-45 in patients with Duchenne muscular dystrophy. Following the announcement, the stock fell 15.23% to $4.119. The trial met primary safety and tolerability objectives, with no serious adverse events leading to discontinuation, but no functional benefits were observed at this early stage. Future cohorts will test higher doses, with data expected in the first half of 2027. https://www.openbell.ai/news/GENB:1792001718517 2026-10-14T18:15:18.517Z daily 0.9 https://cdn.brandfetch.io/GENB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market Generate Biomedicines Inc. has entered a strategic partnership with Zealand Pharma A/S to develop AI-engineered protein therapies targeting obesity and other metabolic diseases. The agreement includes an upfront payment of $30 million and potential milestone payments totaling nearly $1.2 billion across two initial programs. Generate will lead research and drug design, while Zealand Pharma will handle clinical development and commercialization. Generate's stock was up 0.86% at $12.36 following the announcement. https://www.openbell.ai/news/GENB:1792001698088 2026-10-14T18:14:58.088Z daily 0.9 https://cdn.brandfetch.io/GENB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market Generate Biomedicines Inc. has entered a strategic partnership with Zealand Pharma A/S to develop AI-engineered protein therapies targeting obesity and metabolic diseases. The agreement includes an upfront payment of $30 million and potential milestone payments totaling nearly $1.2 billion across two initial programs. Generate will lead research and drug design, while Zealand Pharma will manage clinical development and commercialization. At the time of publication, Generate's stock was trading at $12.36, reflecting a 0.86% increase. https://www.openbell.ai/news/TRDA:1792001695213 2026-10-14T18:14:55.213Z daily 0.9 https://cdn.brandfetch.io/TRDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With Entrada Therapeutics Stock Wednesday? Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported topline results from its Phase 1/2 ELEVATE-45-201 clinical trial, evaluating the drug ENTR-601-45 for Duchenne muscular dystrophy. Following the announcement, the stock fell by 15.23%, trading at $4.119. The trial showed a favorable safety profile, with no participant discontinuations, while early efficacy signals indicated a 0.10% mean increase in dystrophin production in treated patients. Future cohorts will test higher doses, with data expected in the first half of 2027. https://www.openbell.ai/news/GENB:1792001672969 2026-10-14T18:14:32.969Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Obesity-Rate-Reference.jpg?width=250&height=187 Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market Generate Biomedicines Inc. has entered a strategic partnership with Zealand Pharma A/S to develop AI-engineered protein therapies targeting obesity and other metabolic diseases. The agreement includes an upfront payment of $30 million, with potential milestone payments totaling nearly $1.2 billion across two initial programs. Generate will lead research and drug design, while Zealand Pharma will manage clinical development and commercialization. Following the announcement, Generate's stock price increased by 0.86% to $12.36. https://www.openbell.ai/news/TRDA:1792001670687 2026-10-14T18:14:30.687Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Genetic-Research-And-Biotech-Science-Con.jpg?width=250&height=187 What's Going On With Entrada Therapeutics Stock Wednesday? Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported topline results from its Phase 1/2 ELEVATE-45-201 clinical trial, evaluating the drug ENTR-601-45 for Duchenne muscular dystrophy. Following the announcement, the stock fell 15.23% to $4.119. The trial demonstrated a favorable safety profile, with no participant discontinuations, but functional benefits were not observed at this early stage. Future cohorts will test higher doses, with data expected in the first half of 2027. https://www.openbell.ai/news/TWLO:1792001623672 2026-10-14T18:13:43.672Z daily 0.9 https://cdn.brandfetch.io/TWLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud B of A Securities Maintains Buy on Twilio, Raises Price Target to $320 B of A Securities analyst Koji Ikeda has maintained a 'Buy' rating on Twilio (NYSE: TWLO) and raised the price target from $270 to $320. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/FCX:1792001491327 2026-10-14T18:11:31.327Z daily 0.9 https://cdn.brandfetch.io/FCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of copper-related companies are trading lower amid a decline in copper prices and a stronger U.S. dollar following hotter-than-expected inflation data. openbell Financial News https://www.openbell.ai/news/ENPH:1792001458633 2026-10-14T18:10:58.633Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Enphase-Energy-Inc.jpg?width=250&height=187 Why Is Enphase Energy Stock Falling Wednesday? Enphase Energy, Inc. (NASDAQ: ENPH) saw its stock price drop over 9% on Wednesday, trading at $29.04, following analysts' reductions in price forecasts amid a broader market selloff. Morgan Stanley lowered its price target from $27 to $24, while Susquehanna cut its forecast from $37 to $35, and Barclays reduced its target to $44. The company is set to report quarterly earnings on October 27, with analysts predicting earnings of 51 cents per share and a revenue decline to $304.52 million from $410.43 million a year earlier. https://www.openbell.ai/news/AVGO:1792001380372 2026-10-14T18:09:40.372Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Broadcom-Irvine-Campus-Interior-Hallway-.jpg?width=250&height=187 Why Is Broadcom Stock Falling on Wednesday? Broadcom Inc. (NASDAQ: AVGO) stock fell 3.30% to $345.32 amid a broader sell-off in semiconductor stocks, with the Nasdaq down 1.65% and the S&P 500 down 1.02%. CEO Hock Tan's recent comments on AI investments, suggesting that many investors have unrealistic expectations, contributed to the decline. Despite reporting $16.7 billion in AI semiconductor revenue for Q3, up 221% year-over-year, and forecasting $21.7 billion for Q4, concerns about profitability in the AI sector persist. https://www.openbell.ai/news/HSAI:1792001324798 2026-10-14T18:08:44.798Z daily 0.9 https://cdn.brandfetch.io/HSAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hesai Group Launches Kosmo 3D World Data Engine For Physical AI, Announces Partnerships With Galbot And Dexmal Hesai Group (NASDAQ: HSAI) has launched Kosmo, a 3D world data engine aimed at enhancing access to high-quality real-world data for Physical AI applications. The Kosmo system integrates the Kosmo One AI spatial camera with the Kosmo World cloud platform, facilitating the creation of 3D digital spaces for various uses. Additionally, Hesai announced strategic partnerships with Galbot and Dexmal, showcasing applications in robotics, filmmaking, and location services. https://www.openbell.ai/news/PRCH:1792001296070 2026-10-14T18:08:16.070Z daily 0.9 https://cdn.brandfetch.io/PRCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud B. Riley Securities Maintains Buy on Porch Group, Raises Price Target to $24 B. Riley Securities analyst Randy Binner has maintained a Buy rating on Porch Group (NASDAQ: PRCH) and raised the price target from $21 to $24. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/PRCH:1792001176933 2026-10-14T18:06:16.933Z daily 0.9 https://cdn.brandfetch.io/PRCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Craig-Hallum Maintains Buy on Porch Group, Raises Price Target to $22 Craig-Hallum analyst Jason Kreyer has maintained a 'Buy' rating on Porch Group (NASDAQ: PRCH) and raised the price target from $20 to $22. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/GFI:1792001024907 2026-10-14T18:03:44.907Z daily 0.9 https://cdn.brandfetch.io/GFI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of precious metals-related companies are trading lower after stronger-than-expected inflation data boosted expectations for a Federal Reserve rate hike in October. Gold and silver prices are declining amid a stronger U.S. dollar and rising Treasury yields, which make non-yielding precious metals less attractive to investors. openbell Financial News https://www.openbell.ai/news/GXO:1792000750871 2026-10-14T17:59:10.871Z daily 0.9 https://cdn.brandfetch.io/GXO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Upgrades GXO Logistics to Buy, Maintains Price Target to $61 Goldman Sachs analyst Patrick Creuset has upgraded GXO Logistics (NYSE: GXO) from Neutral to Buy. The firm has maintained its price target for the stock at $61. https://www.openbell.ai/news/IBRX:1792000737065 2026-10-14T17:58:57.065Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/FDA-Warns-About-Salmonella-Risks.jpg?width=250&height=187 Why Is ImmunityBio Stock Gaining Wednesday? ImmunityBio Inc. (NASDAQ: IBRX) received expanded FDA approval for its drug nogapendekin alfa inbakicept-pmln (Anktiva) for adults with BCG-unresponsive non-muscle invasive bladder cancer, leading to a stock increase of over 5% to $10.32. The approval now includes high-grade papillary tumors alongside the previously covered carcinoma in situ. Trading volume surged to 19.72 million shares, significantly above the 100-day average of 10.38 million shares. https://www.openbell.ai/news/CARR:1792000311525 2026-10-14T17:51:51.525Z daily 0.9 https://cdn.brandfetch.io/CARR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Downgrades Carrier Global to Neutral, Lowers Price Target to $61 Goldman Sachs analyst Joe Ritchie has downgraded Carrier Global (NYSE: CARR) from a Buy rating to Neutral. The price target for the stock has been reduced from $74 to $61. https://www.openbell.ai/news/ASML:1792000236031 2026-10-14T17:50:36.031Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/ASML-Holdings-NV.jpg?width=250&height=187 ASML Says AI Boom Is Boosting Pricing Power as Chipmakers Agree to Pay More ASML Holding N.V. has successfully negotiated higher prices for its critical chipmaking equipment, driven by the AI boom, which is expected to enhance its revenue and profit margins starting in 2027. The company, the sole supplier of extreme ultraviolet lithography machines, noted that its output for 2027 and 2028 will not fully satisfy customer demand. ASML reported a gross margin of 57.5% in Q3 and anticipates a slight decrease to around 57% in Q4 due to production expansion costs. Despite the positive outlook, ASML's U.S.-listed shares fell 1% on the same day. https://www.openbell.ai/news/LII:1792000205689 2026-10-14T17:50:05.689Z daily 0.9 https://cdn.brandfetch.io/LII/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Downgrades Lennox International to Neutral, Lowers Price Target to $390 Goldman Sachs analyst Joe Ritchie has downgraded Lennox International (NYSE: LII) from a Buy rating to Neutral. The price target for the company's stock has been reduced from $547 to $390. https://www.openbell.ai/news/DAL:1792000150334 2026-10-14T17:49:10.334Z daily 0.9 https://cdn.brandfetch.io/DAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of airline companies are trading lower amid elevated oil prices and stronger-than-expected inflation data. Elevated fuel costs and rising Treasury yields are fueling concerns about persistent inflation and increased financing costs, which could pressure airline profitability and weigh on passenger demand. openbell Financial News https://www.openbell.ai/news/TT:1792000123682 2026-10-14T17:48:43.682Z daily 0.9 https://cdn.brandfetch.io/TT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Upgrades Trane Technologies to Buy, Raises Price Target to $565 Goldman Sachs analyst Joe Ritchie has upgraded Trane Technologies (NYSE: TT) from Neutral to Buy. The price target for the stock has been raised from $548 to $565. https://www.openbell.ai/news/WU:1792000061505 2026-10-14T17:47:41.505Z daily 0.9 https://cdn.brandfetch.io/WU/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Underweight on Western Union, Lowers Price Target to $7 JP Morgan analyst Tien-Tsin Huang has maintained an Underweight rating on Western Union (NYSE: WU) and has lowered the price target from $8 to $7. https://www.openbell.ai/news/DELL:1792000051404 2026-10-14T17:47:31.404Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Dell-Technologies-Logo-Displayed-On-A-Sm.jpg?width=250&height=187 Why Is Dell Technologies Stock Sinking Wednesday? Dell Technologies Inc. stock fell over 11% on Wednesday following a downgrade by Barclays from Overweight to Equal-Weight, with the price target reduced from $603 to $574. Despite this decline, Dell's shares have increased more than 300% in 2026 due to strong AI server orders and a growing enterprise backlog. CEO Michael Dell expressed optimism about the demand for AI infrastructure, which he believes will continue to exceed supply through 2030, while highlighting the need for significant investments in computing infrastructure as enterprise adoption of AI begins to grow. https://www.openbell.ai/news/CME:1791999903619 2026-10-14T17:45:03.619Z daily 0.9 https://cdn.brandfetch.io/CME/w/400/h/400?c=1idopYfmtR7ZKg8QMud CME Group shares are trading higher after Wells Fargo raised its price target on the stock from $301 to $315. openbell Financial News https://www.openbell.ai/news/VNOM:1791999828084 2026-10-14T17:43:48.084Z daily 0.9 https://cdn.brandfetch.io/VNOM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Viper Energy, Raises Price Target to $53 Truist Securities analyst Gabe Daoud has maintained a Buy rating on Viper Energy (NASDAQ: VNOM) and increased the price target from $52 to $53. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/VST:1791999562517 2026-10-14T17:39:22.517Z daily 0.9 https://cdn.brandfetch.io/VST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of power and electrical-related companies are trading lower as elevated oil prices and stronger-than-expected inflation data fuel expectations that U.S. interest rates will remain higher for longer. Rising financing costs could pressure capital spending on power infrastructure and data center projects, weighing on demand for electrical equipment and related solutions. openbell Financial News https://www.openbell.ai/news/WMT:1791999544782 2026-10-14T17:39:04.782Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Walmart-Beats-Estimates.jpg?width=250&height=187 Walmart Stock Moves Higher: What's Happening? Walmart Inc. (NASDAQ: WMT) shares increased by 2.71% to $115.32, as the company gained traction in a market where most sectors declined, particularly in technology. The Consumer Staples Select Sector SPDR Fund rose by 1.49%, indicating a shift in investor preference towards consumer staples. Additionally, Walmart announced plans to offer over 250 prescription drugs for free to employees, aiming to attract and retain staff amid rising healthcare costs.